Koyel Banerjee, Priyabrata Das, Rittwika Bhattacharya, Swati Dasgupta, Soma Mukhopadhyay, Jayasri Basak, Ashis Mukhopadhyay
Department of Molecular Biology, Netaji Subhas Chandra Bose Cancer Research Institute, 16 A Park Lane, Kolkata, 700016 India.
Department of Haemato-Oncology, Netaji Subhas Chandra Bose Cancer Research Institute, 16 A Park Lane, Kolkata, West Bengal 700016 India.
Indian J Surg Oncol. 2017 Dec;8(4):462-468. doi: 10.1007/s13193-017-0651-4. Epub 2017 Apr 8.
Carcinoembryonic antigen (CEA) is an important deterministic factor in predicting colorectal carcinoma (CRC) progression. It is also evident that microsatellite instability (MSI) which results in a hypermutable phenotype of genomic DNA is common in CRC. Owing to the scarcity of reports from India, our aim of this study was to understand the clinicopathological correlations of CEA status with surgery and chemotherapy, correlate the same with socio-demographic status of the patients, determine the MSI status amongst them and understand the prognostic implications of CEA and MSI as CRC progression marker amongst patients. The serum CEA level was estimated by chemiluminescence assay (CLIA). Serum liver enzyme assay was carried out following the manufacturer's instructions using auto-analysers (E. Merck and Sera mol. Health Care, India). MSI analysis was carried out by PCR-SSCP. From our study, most frequently detected colorectal cancer was in 40-49 years age group (25.26%) with 61.05% male and 38.95% females. CEA showed a significant association with higher TNM staging, tumour size, smoking habit and MSI status ( < 0.05) but not with sex and site of cancer ( > 0.05). After surgery and chemotherapy, CEA and WBCs were decreased significantly ( < 0.05), while liver enzymes did not change significantly ( > 0.05). Overall, microsatellite instability was observed in approximately 40% of the populations. From our study, it was also evident that for both, MSI and abnormal CEA level predicted poor prognosis for the patient (by using Kaplan-Meier survival analysis; = 0.04). Thus, CEA and initial MSI status can be used as prognostic markers of CRC.
癌胚抗原(CEA)是预测结直肠癌(CRC)进展的重要决定因素。同样明显的是,导致基因组DNA高突变表型的微卫星不稳定性(MSI)在CRC中很常见。由于印度的相关报道较少,本研究的目的是了解CEA状态与手术和化疗的临床病理相关性,将其与患者的社会人口统计学状态相关联,确定其中的MSI状态,并了解CEA和MSI作为CRC患者进展标志物的预后意义。血清CEA水平通过化学发光免疫分析(CLIA)进行测定。血清肝酶分析按照制造商的说明使用自动分析仪(德国默克公司和印度Sera mol. Health Care公司)进行。MSI分析通过聚合酶链反应-单链构象多态性(PCR-SSCP)进行。在我们的研究中,最常检测到的结直肠癌发生在40-49岁年龄组(25.26%),男性占61.05%,女性占38.95%。CEA与较高的TNM分期、肿瘤大小、吸烟习惯和MSI状态显著相关(P<0.05),但与性别和癌症部位无关(P>0.05)。手术和化疗后,CEA和白细胞显著下降(P<0.05),而肝酶没有显著变化(P>0.05)。总体而言,约40%的人群中观察到微卫星不稳定性。从我们的研究中还可以明显看出,对于MSI和异常CEA水平,两者均预示患者预后不良(通过Kaplan-Meier生存分析;P=0.04)。因此,CEA和初始MSI状态可作为CRC的预后标志物。